Ravulizumab for relapse prevention in AQP4-IgG-positive neuromyelitis optica spectrum disorder: a 2-year follow-up case report. Akkawi N, Mohamed E H, Shatila A Front Med (Lausanne). 2026; 13:1827687. PMID: 42369157. Abstract CommentRecommendBookmarkWatch
